High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$455K
$455,110
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ESPR |
Esperion Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2026-03-17 | $69,547 | S | Form 4 |
| ESPR |
Esperion Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2026-03-17 | $17,377 | S | Form 4 |
|
ESPR
S
Esperion Therapeutics, Inc.
Looker Benjamin
• Officer • Chief Legal Officer
Discretionary Sell
2026-03-17
$15,429
|
||||||
| ESPR |
Esperion Therapeutics, Inc.
|
Officer • Chief Legal Officer
Discretionary Sell
|
2026-03-17 | $15,429 | S | Form 4 |
|
ESPR
S
Esperion Therapeutics, Inc.
Looker Benjamin
• Officer • General Counsel
Discretionary Sell
2026-01-20
$4,868
|
||||||
| ESPR |
Esperion Therapeutics, Inc.
|
Officer • General Counsel
Discretionary Sell
|
2026-01-20 | $4,868 | S | Form 4 |
|
ESPR
S
Esperion Therapeutics, Inc.
Looker Benjamin
• Officer • General Counsel
Discretionary Sell
2025-12-17
$23,898
|
||||||
| ESPR |
Esperion Therapeutics, Inc.
|
Officer • General Counsel
Discretionary Sell
|
2025-12-17 | $23,898 | S | Form 4 |
| ESPR |
Esperion Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-12-17 | $26,905 | S | Form 4 |
| ESPR |
Esperion Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-12-17 | $177,200 | S | Form 4 |
|
ESPR
S
Esperion Therapeutics, Inc.
Looker Benjamin
• Officer • General Counsel
Discretionary Sell
2025-10-17
$3,275
|
||||||
| ESPR |
Esperion Therapeutics, Inc.
|
Officer • General Counsel
Discretionary Sell
|
2025-10-17 | $3,275 | S | Form 4 |
| ESPR |
Esperion Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-09-17 | $19,785 | S | Form 4 |
|
ESPR
S
Esperion Therapeutics, Inc.
Looker Benjamin
• Officer • General Counsel
Discretionary Sell
2025-09-17
$17,573
|
||||||
| ESPR |
Esperion Therapeutics, Inc.
|
Officer • General Counsel
Discretionary Sell
|
2025-09-17 | $17,573 | S | Form 4 |
| ESPR |
Esperion Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-09-17 | $79,254 | S | Form 4 |